FORCESI, EMANUELE

FORCESI, EMANUELE  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.017 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio 2018-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. 2017-01-01 NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES - 1.01 Articolo in rivista j.numecd.2017.10.008.pdf
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; El...isa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi 2019-01-01 MULTIPLE SCLEROSIS - 1.01 Articolo in rivista -
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele;... Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta* 2019-01-01 PLOS ONE - 1.01 Articolo in rivista journal.pone.0211938.pdf
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS Lunghi, C; Antonazzo, IC; Poluzzi, E; Burato, S; Raschi, E; Forcesi, E; Sangiorgi, E; Menchetti, ...M; Roberge, P 2019-01-01 VALUE IN HEALTH - 1.06 Abstract in rivista -
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; B...aldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta 2018-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System Mei, Riccardo; Raschi, Emanuel; Forcesi, Emanuele; Diemberger, Igor; De Ponti, Fabrizio; Poluzzi,... Elisabetta 2018-01-01 INTERNATIONAL JOURNAL OF CARDIOLOGY - 1.01 Articolo in rivista -
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. 2020-01-01 ACTA DIABETOLOGICA - 1.01 Articolo in rivista -
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti ...M.; Roberge P.; Poluzzi E. 2020-01-01 NEUROPSYCHIATRIC DISEASE AND TREATMENT - 1.01 Articolo in rivista lunghi et al. 2020.pdf
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. 2020-01-01 ACTA DIABETOLOGICA - 1.04 Replica / breve intervento (e simili) -
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System Raschi E.; Mazzarella A.; Antonazzo I.C.; Bendinelli N.; Forcesi E.; Tuccori M.; Moretti U.; Polu...zzi E.; De Ponti F. 2019-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista Raschi 2019.pdfsuppl 1.pdfsupplemento 2.pdf